Dr Reddys Laboratories Share Price Today - Live Blog for July 29, 2025

After a -0.12% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,298.85. The stock has a PE ratio of 18.9000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.07%. At this moment, it's actively trading at ₹1,299.60, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd experienced a -0.01% dip in its share price and is currently trading at ₹1,299.85. The stock has a PE ratio of 18.9000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a remarkable 0.03% surge in its share price and is presently trading at ₹1,300.00. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's stock has surged by 0.37%, and it is currently trading at ₹1,300.00. Additionally, the stock maintains a PE ratio of 18.9000, while the industry PE is 35.6163.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.43% recently. As of now, this stock is actively trading at a current market price of ₹1,296.35 per share, attracting attention from investors.

The share price of Dr Reddys Laboratories Ltd plunged by -0.04%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,291.20, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's stock price surged by 0.18%, reaching the current market value of ₹1,291.75 per share. This surge is a testament to the stock's recent performance.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,289.40. The stock is currently trading at a PE of 18.9000, while the industry PE is 35.6163, prompting investors to assess its value proposition.

Following a noteworthy 0.03% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,290.80. When it comes to valuation, this stock has a PE ratio of 18.9000, with the industry PE ratio at 35.6163.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.05%, reaching the current market price of ₹1,290.30. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.03%, and as of now, it's trading at ₹1,289.70 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd experienced a -0.05% downturn in its share price, and it's currently trading at ₹1,289.25. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.00%, signalling a challenging period. Currently trading at ₹1,290.15, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.08%, reaching the current market price of ₹1,288.90. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd experienced a -0.09% downturn in its share price, and it's currently trading at ₹1,287.85. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd plunged by -0.01%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,289.05, but investors are assessing whether this is a temporary dip or a long-term trend.

After a notable 0.07% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,289.25. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,288.40, captivating the attention of market participants.

The share price of Dr Reddys Laboratories Ltd experienced a -0.18% slump and is currently trading at ₹1,287.70. While the stock maintains a PE ratio of 18.9000, the industry PE is 35.6163, raising questions about valuation.

Dr Reddys Laboratories Ltd witnessed a substantial 0.12% increase in its share price and is currently trading at ₹1,289.20. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.29% drop, and it's now trading at ₹1,287.65 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd witnessed a notable 0.23% surge in its share price and is presently trading at ₹1,287.55, captivating the attention of market participants.

Dr Reddys Laboratories Ltd observed a remarkable 0.23% surge in its share price and is presently trading at ₹1,287.55. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd shares experienced a -0.20% reduction, with the current market price at ₹1,284.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.06%, a situation worth noting. At present, the stock is trading at ₹1,289.20. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.9000, while the industry PE ratio is 35.6163.